Longevity of middle east respiratory syndrome coronavirus antibody responses in humans, saudi arabia
Emerging Infectious Diseases, Volume 27, No. 5, Year 2021
Notification
URL copied to clipboard!
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specifi c neutralizing antibodieswere detected for 6 years postinfection.